ICRA Limited · Bliss GVS Pharma Limited: Ratings placed on Watch with Developing ImplicationsICRA Limited · PDF preserved by IndiaTicker
Archived PDF Company dossier
Bliss GVS Pharma
NSE:BLISSGVS · ISIN INE416D01022
- Close
- ₹456 29 Jul 2026
- Daily change
- N/A Exchange close
- Evidence state
- Building 0/0 checks
Bliss GVS Pharma
Ratings & risks
Credit signals
Agency evidenceRating-action history
ICRA Limited · Bliss GVS Pharma Limited: [ICRA]A-(Stable)/[ICRA] A2+; assignedICRA Limited · PDF preserved by IndiaTicker
Archived PDF ICRA Limited · ICRA suspends ratings for bank facilities of Bliss GVS Pharma LimitedICRA Limited · discovered
Agency source ICRA Limited · ICRA revises ratings for Bliss GVS Pharma Limitedâs bank facilities to [ICRA]BB+ (stable) and [ICRA]A4+ICRA Limited · discovered
Agency source Risk research framework
Analyst reviewQuestions to test against evidence
Operating deterioration
HighTrack sector-specific operating metrics and reconcile them across reporting periods.
Funding and liquidity
HighReview debt maturity, repricing, liquidity and rating commentary where relevant.
Execution versus guidance
MediumCompare management statements with subsequent reported delivery.
Governance and key-person change
MediumConnect management transitions, related parties and auditor observations.